Mitochondrial dysfunction in human TDP-43 transfected NSC34 cell lines and the protective effect of dimethoxy curcumin

Brain Research Bulletin

Volumn 89, Issue 5-6, 2012, Pages 185-190

  Lu, Jinsheng ^a   Duan, Weisong ^a,b   Guo, Yansu ^a,b   Jiang, Hong ^a   Li, Zhongyao ^a,b   Huang, Jing ^a,b   Hong, Kun ^a   Li, Chunyan ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Institute of Cardiocerebrovascular Disease   (China)

Author keywords

ALS; Dimethoxy curcumin; Electron transport chain; Mitochondrial transmembrane potential; TDP 43; UCP2

Indexed keywords

CURCUMIN; DIMETHOXYCURCUMIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL PROTECTION; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; SPECTROPHOTOMETRY; WESTERN BLOTTING;

CELL LINE; CURCUMIN; CYTOPROTECTION; DNA-BINDING PROTEINS; HUMANS; MITOCHONDRIA; TRANSFECTION;

EID: 84867862569     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.09.005     Document Type: Article

References (30)

1. Andrews Z.B., Rivera A., Elsworth J.D., Roth R.H., Agnati L., Gago B., Abizaid A., Schwartz M., Fuxe K., Horvath T.L. Uncoupling protein-2 promotes nigrostriatal dopamine neuronal function. European Journal of Neuroscience 2006, 24:32-36.
2. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications 2006, 351:602-611.
3. Boillee S., Vande Velde C., Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52:39-59.
4. Borthwick G.M., Johnson M.A., Ince P.G., Shaw P.J., Turnbull D.M. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Annals of Neurology 1999, 46:787-790.
5. Braun R.J., Sommer C., Carmona-Gutierrez D., Khoury C.M., Ring J., Buttner S., Madeo F. Neurotoxic 43-kDa TAR DNA-binding protein (TDP-43) triggers mitochondrion-dependent programmed cell death in yeast. Journal of Biological Chemistry 2011, 286:19958-19972.
6. Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience 2004, 27:723-749.
7. Buratti E., Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. Journal of Biological Chemistry 2001, 276:36337-36343.
8. Cairns N.J., Neumann M., Bigio E.H., Holm I.E., Troost D., Hatanpaa K.J., Foong C., White C.L., Schneider J.A., Kretzschmar H.A., Carter D., Taylor-Reinwald L., Paulsmeyer K., Strider J., Gitcho M., Goate A.M., Morris J.C., Mishra M., Kwong L.K., Stieber A., Xu Y., Forman M.S., Trojanowski J.Q., Lee V.M., Mackenzie I.R. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. American Journal of Pathology 2007, 171:227-240.
9. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience 2001, 2:806-819.
10. Conti B., Sugama S., Lucero J., Winsky-Sommerer R., Wirz S.A., Maher P., Andrews Z., Barr A.M., Morale M.C., Paneda C., Pemberton J., Gaidarova S., Behrens M.M., Beal F., Sanna P.P., Horvath T., Bartfai T. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity. Journal of Neurochemistry 2005, 93:493-501.
11. Duan W., Li X., Shi J., Guo Y., Li Z., Li C. Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell. Neuroscience 2010, 169:1621-1629.
12. Gitcho M.A., Baloh R.H., Chakraverty S., Mayo K., Norton J.B., Levitch D., Hatanpaa K.J., White C.L., Bigio E.H., Caselli R., Baker M., Al-Lozi M.T., Morris J.C., Pestronk A., Rademakers R., Goate A.M., Cairns N.J. TDP-43 A315T mutation in familial motor neuron disease. Annals of Neurology 2008, 63:535-538.
13. Gottlieb R.A., Adachi S. Nitrogen cavitation for cell disruption to obtain mitochondria from cultured cells. Methods in Enzymology 2000, 322:213-221.
14. Israelson A., Arbel N., Da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., Cleveland D.W. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 2010, 67:575-587.
15. Janssen A.J., Trijbels F.J., Sengers R.C., Smeitink J.A., van den Heuvel L.P., Wintjes L.T., Stoltenborg-Hogenkamp B.J., Rodenburg R.J. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clinical Chemistry 2007, 53:729-734.
16. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.F., Camu W., Meininger V., Dupre N., Rouleau G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nature Genetics 2008, 40:572-574.
17. Kong J., Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. Journal of Neuroscience 1998, 18:3241-3250.
18. Mattiasson G., Sullivan P.G. The emerging functions of UCP2 in health, disease, and therapeutics. Antioxidants and Redox Signalling 2006, 8:1-38.
19. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
20. Ohori H., Yamakoshi H., Tomizawa M., Shibuya M., Kakudo Y., Takahashi A., Takahashi S., Kato S., Suzuki T., Ishioka C., Iwabuchi Y., Shibata H. Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Molecular Cancer Therapeutics 2006, 5:2563-2571.
21. Ou S.H., Wu F., Harrich D., Garcia-Martinez L.F., Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. Journal of Virology 1995, 69:3584-3596.
22. Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nature Reviews Neuroscience 2006, 7:710-723.
23. Pon L.A., Schon E.A. American society for cell biology. Mitochondria 2007, Academic Press, Amsterdam/Boston. 2nd ed.
24. Shan X., Chiang P.M., Price D.L., Wong P.C. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:16325-16330.
25. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
26. Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., Steinbart E., McCluskey L., Grossman M., Neumann M., Wu I.L., Yang W.S., Kalb R., Galasko D.R., Montine T.J., Trojanowski J.Q., Lee V.M., Schellenberg G.D., Yu C.E. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurology 2008, 7:409-416.
27. Vande Velde C., Miller T.M., Cashman N.R., Cleveland D.W. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:4022-4027.
28. Wiedemann F.R., Manfredi G., Mawrin C., Beal M.F., Schon E.A., Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. Journal of Neurochemistry 2002, 80:616-625.
29. Xu Y.F., Gendron T.F., Zhang Y.J., Lin W.L., D'Alton S., Sheng H., Casey M.C., Tong J., Knight J., Yu X., Rademakers R., Boylan K., Hutton M., McGowan E., Dickson D.W., Lewis J., Petrucelli L. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. Journal of Neuroscience 2010, 30:10851-10859.
30. Yang Z., Chang Y.J., Yu I.C., Yeh S., Wu C.C., Miyamoto H., Merry D.E., Sobue G., Chen L.M., Chang S.S., Chang C. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nature Medicine 2007, 13:348-353.